Article Details
Retrieved on: 2021-02-01 21:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AFFIRM-AL is expected to initiate mid-2021. The significant survival benefit observed in VITAL with birtamimab was further supported by evidence of ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here